Bank Of New York Mellon Corp Cidara Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.75 - $1.98 $55,657 - $146,935	74,210 New	74,210 $94.2 Million
Q1 2021 May 13, 2021	BUY	$2.06 - $3.01 $3,017 - $4,409	1,465 Added 1.86%	80,273 $213,000
Q4 2020 Feb 09, 2021	SELL	$1.99 - $3.25 $8,081 - $13,198	-4,061 Reduced 4.9%	78,808 $157,000
Q3 2020 Nov 12, 2020	SELL	$2.85 - $4.1 $1,604 - $2,308	-563 Reduced 0.67%	82,869 $236,000
Q2 2020 Aug 12, 2020	BUY	$2.39 - $4.0 $199,402 - $333,728	83,432 New	83,432 $307,000

Q2 2019 Aug 12, 2019	SELL	$1.49 - $2.94 $29,670 - $58,544	-19,913 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$2.35 - $3.27 $46,795 - $65,115	19,913 New	19,913 $53,000

22.1M

2.7K

100

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $889M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.